Sthree Share Discussion Threads

[abally99] 22/5/2008 07:18

Stem Cell Sciences plc (AIM:STEM, ASX:STC) today announced the launch of Culticell iSTEM,
a novel, serum-free, feeder-free embryonic
stem (ES) cell research media product, that maintains cells in their basal, pluripotent state.

Culticell iSTEM provides researchers with a purer starting point for investigating the biological potential of ES cells.

"Professor Smith's research is a major step forward in embryonic stem cell research and
elucidates some of the early mechanisms involved
in self-renewal and differentiation," noted Dr Tim Allsopp, Chief Scientific Officer of Stem
Cell Sciences. "We have now leveraged this
significant advance into our novel media product Culticell iSTEM, which we believe will help
provide researchers with a more pure starting
point for embryonic stem cell research."

Interesting stuff !

[the_doctor] 20/5/2008 21:13

Nope, but those with stem cell IP (whoever they are) will start seeing more action IMO

[hyper al] 20/5/2008 21:12

Anyone in these?

[the_doctor] 26/3/2008 13:29

not actually a doctor
but that said, probably more qualified than a Dr to look into the health of this company.
not a lot of time these days, but will post my findings if I get around to looking into it.

The UK MPs wont stop the work SCS does... and if that work produces the desired results, they will have to change their views.
ie. looks like sentiment is unfairly hitting this

[the_doctor] 25/3/2008 19:23

Might take a look into this.
If cash levels are ok and they have decent proprietary tech, it could be a worthwhile punt on bid prospects??

[paul augustus] 18/2/2008 17:17

pa.press.net
Monday, 18 February 2008

--------------------------------------------------------------------------------
Stem cells 'speed up body repairs'Stem cells 'speed up body repairs'
Scientists are developing a revolutionary way to mend damaged bones and cartilage using a patient's own stem cells.

They are working on a way of making stem cells grow into bone and cartilage in the patient's body to speed up the repair process.

The research at the University of Edinburgh could have a major impact on helping trauma victims whose bones have been shattered beyond repair, and treating conditions such as osteoarthritis, scientists said.

The process would involve taking stem cells from a patient's bone marrow and culturing them to turn into bone or cartilage cells.

These cells would then be placed inside a "bioactive scaffold" made of a fairly rigid mesh structure impregnated with molecules that benefit the cells.

This would be placed inside the patient's body at the site of the injury to boost the healing process.

The scaffold would protect the stem cells, while the molecules would stimulate their growth into bone or cartilage.

Dr Brendon Noble, of the University of Edinburgh's MRC Centre for Regenerative Medicine, said: "We hope that this will kick start the body's natural healing processes, enabling cells to grow and carry out repair to the damaged area. Half of us have some form of orthopaedic surgery at some point in our lives.

"Although the specific group of patients who would receive the most benefit from such therapy have yet to be determined, we envisage a number of scenarios where this therapy could be used for cartilage injuries or severe fractures."

He said it could be useful for helping elderly patients, whose bones repair slowly, or people who have suffered high energy fractures such as the kind sustained in road accidents, and could also help people with cartilage damage.

[don muang] 15/2/2008 14:55

Under present circumstances then seems Scotland was one just too many locations to be operating from. Let's see with hindsight if this was the low point for Stem in terms of share price?

[pegasus59] 15/2/2008 10:43

Sorry to see them leaving Scotland

peg

[paul augustus] 08/2/2008 19:13

Been watching this since 80p - can't be long before it's time to jump in.

[cheading] 20/11/2007 09:53

New CEO appointed. The right people are being put on the bus, in the right seats and pointed in the right direction.

cheers

cheading

[cheading] 16/11/2007 13:34

praps they like the Co. I do too. Management, management, management.

cheers

cheading

[don muang] 15/11/2007 17:50

Any thoughts why people were paying 0.82 (Aus$) towards end of Aus trading today....?

[don muang] 09/11/2007 07:16

So, SCS plc and SCS KK have parted company ... with SCS plc securing all outstanding rights to commercialise its neural stem (NS) cell
technology for both research and stem-cell based therapies. So seems this leaves SCS plc to concentrate more on fully developing the commercial potential
of its stem cell technologies in basic and applied research.At least price in AUS has stabilized today.

[cheading] 09/11/2007 01:09

lamanga2004

New management ($billion boy) and deals being signed. Your shout, NAG.

cheers

cheading

[don muang] 29/10/2007 14:15

The cash position of #5.3m/AU$13.25m as at 30 June 2007(2006: #3.5m) is
after allowing for expenditure of #0.8m/$2.0m on R&D activities

[the_doctor] 29/10/2007 14:12

I havent looked into it yet, but it could probably jump massively on a deal?

Not sure what their cash situation looks like.

[lamanga2004] 29/10/2007 12:59

With an average of only a few thousand shares traded each day since Aug 22nd, and the share price walking itself down about 7p (or 20%) since then, can anyone give me a good reason to put my money here?

What projects do they have in the pipeline?

[don muang] 24/9/2007 04:40

All quiet with the company itself so here's a brief guide to what are stem cells...

[cheading] 22/8/2007 07:09

Despite the slow price drift, nothing has changed. Prospects HAVE improved in the last month, AND the lack of price fall in the last week, depite big market panics, says this share is in strong and patient hands.

cheers

cheading

[412069] 15/8/2007 08:59

Cheading, been watching this since they teamed up with HML, i agree Bargin once the herd arrive.

[cheading] 15/8/2007 08:27

It appears I'm talking to myself? Broad US Patent.

CEO "The value of such fundamental, proprietary technology cannot be underestimated, particularly in such a competitive and rapidly growing industry. Stem Cell Sciences has always placed great emphasis on using patent law to maximise revenue opportunity".

One to tuck away.

cheers

cheading

[cheading] 16/7/2007 16:52

Bargain when the herd arrive.

cheers

cheading

[don muang] 13/7/2007 13:54

well, someone's 'happy' to pick-up £7.8k worth at 39p...